Lung Cancer
January 2015
This bulletin covers aspects of lung cancer and should be of interest to multidisciplinary teams
working in this area.
Sections can include:
 Combined Modality Therapies
 Drug Therapy
 Pathology, Staging, Polymorphisms & Biomarkers
 Prognosis, Survival & Risk Factors
 Radiotherapy & Imaging
 Supportive Care & Symptom Management
 Surgery
 Tobacco & Smoking
Many of the following articles are available online via the NHS Scotland Knowledge Network.
Please use the links where provided and your ATHENS password. A complete list of
available online journals and registration for ATHENS can be found at
www.knowledge.scot.nhs.uk/
If the article you require is not available via the NHS Scotland Knowledge Network and you
would like to request a print copy, please submit your request online at
www.quest.scot.nhs.uk
This bulletin contains a selection of material gathered from a search of the evidence base, and is
not intended to be comprehensive. Professional judgment should be exercised when appraising
the material. The Library takes no responsibility for the wording, content and accuracy of the
information supplied, which has been extracted in good faith from reputable sources. NHSGGC is
not responsible for the content of external internet sites.
Compiled by:
Kirsty Coltart
Subject Librarian
Beatson West of Scotland Cancer Centre
0141 301 7285, kirsty.coltart@ggc.scot.nhs.uk
1
Lung Cancer, January 2015
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
General
Blum T and Schonfeld N. (2015). The lung cancer patient, the pneumologist and
palliative care: a developing alliance. European Respiratory Journal 45,1:211-226.
Ettinger DS, Wood DE, Akerley W, et al. (2014). Non-small cell lung cancer, version
1.2015. Journal of the National Comprehensive Cancer Network 12,12:1738-1761.
Moreira AL and Eng J. (2014). Personalized therapy for lung cancer. Chest
146,6:1649-1657.
Vinod, S.K. (2015). Decision Making in Lung Cancer - How Applicable are the
Guidelines?. Clinical Oncology (Royal College of Radiologists) 27,2:125-131.
Combined Modality Therapies
Shirvani SM, Jiang J, Chang JY, et al. (2014). Lobectomy, sublobar resection, and
stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in
the elderly. JAMA Surgery 149,12:1244-1253.
Drug & Targeted Therapy
Blackhall F, Kim DW, Besse B, et al. (2014). Patient-Reported Outcomes and
Quality of Life in PROFILE 1007: A Randomized Trial of Crizotinib Compared with
Chemotherapy in Previously Treated Patients with ALK-Positive Advanced NonSmall-Cell Lung Cancer. Journal of Thoracic Oncology: Official Publication of the
International Association for the Study of Lung Cancer 9,11:1625-1633.
Camidge DR, Berge EM, Doebele RC, et al. (2014). A Phase II, Open-Label Study of
Ramucirumab in Combination with Paclitaxel and Carboplatin as First-Line
Therapy in Patients with Stage IIIB/IV Non-Small-Cell Lung Cancer. Journal of
Thoracic Oncology: Official Publication of the International Association for the Study of
Lung Cancer 9,10:1532-1539.
Digumarti R, Bapsy PP, Suresh AV, et al. (2014). Bavituximab plus paclitaxel and
carboplatin for the treatment of advanced non-small-cell lung cancer. Lung
Cancer 86,2:231-236.
Ellis PM, Shepherd FA, Millward M, et al. (2014). Dacomitinib compared with
placebo in pretreated patients with advanced or metastatic non-small-cell lung
cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial. Lancet
Oncology 15,12:1379-1388.
Kimura H, Matsui Y, Ishikawa A, et al. (2015). Randomized controlled phase III trial
of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells
in patients with resected primary lung cancer. Cancer Immunology, Immunotherapy
64,1:51-59.
Naito T, Seto T, Takeda K, et al. (2014). Phase II clinical trial of S-1 plus oral
2
Lung Cancer, January 2015
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
leucovorin in previously treated patients with non-small-cell lung cancer. Lung
Cancer 86,3:339-343.
Qi WX, Fu S, Zhang Q, et al. (2015). Anti-epidermal-growth-factor-receptor agents
and complete responses in the treatment of advanced non-small-cell lung
cancer: a meta-analysis of 17 phase III randomized controlled trials. Current
Medical Research & Opinion 31,1:25-33.
Qi WX, Sun YJ, Shen Z, et al. (2015). Risk of interstitial lung disease associated
with EGFR-TKIs in advanced non-small-cell lung cancer: a meta-analysis of 24
phase III clinical trials. Journal of Chemotherapy 27,1:40-51.
Ramalingam SS, Janne PA, Mok T, et al. (2014). Dacomitinib versus erlotinib in
patients with advanced-stage, previously treated non-small-cell lung cancer
(ARCHER 1009): a randomised, double-blind, phase 3 trial. Lancet Oncology
15,12:1369-1378.
Spigel DR, Barlesi F, Felip E, et al. (2014). Efficacy and Safety of Eribulin
Compared with Treatment of Physician's Choice (TPC) in Patients with Advanced
Non-Small-Cell Lung Cancer (NSCLC): Results from a Phase 3 Study: Locally
Advanced Non-small Cell Lung Cancer. International journal of radiation oncology,
biology, physics 90,5:1266.
Zauderer MG, Drilon A, Kadota K, et al. (2014). Trial of a 5-day dosing regimen of
temozolomide in patients with relapsed small cell lung cancers with assessment
of methylguanine-DNA methyltransferase. Lung Cancer 86,2:237-240.
Pathology, Staging, Polymorphisms & Biomarkers
Gentzler RD, Yentz SE, Johnson ML, et al. (2014). The changing landscape of
phase II/III metastatic NSCLC clinical trials and the importance of biomarker
selection criteria. Cancer 120,24:3853-3858.
Malik SM, Pazdur R, Abrams JS, et al. (2014). Consensus Report of a Joint NCI
Thoracic Malignancies Steering Committee: FDA Workshop on Strategies for
Integrating Biomarkers into Clinical Development of New Therapies for Lung
Cancer Leading to the Inception of "Master Protocols" in Lung Cancer. Journal of
Thoracic Oncology: Official Publication of the International Association for the Study of
Lung Cancer 9,10:1443-1448.
Takx RA, Vliegenthart R, Mohamed Hoesein FA, et al. (2015). Pulmonary function
and CT biomarkers as risk factors for cardiovascular events in male lung cancer
screening participants: the NELSON study. European radiology 25,1:65-71.
Tanoue LT, Tanner NT, Gould MK, et al. (2015). Lung cancer screening. American
Journal of Respiratory & Critical Care Medicine 191,1:19-33.
Prognosis, Survival & Risk Factors
3
Lung Cancer, January 2015
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
Dekker A, Vinod S, Holloway L, et al. (2014). Rapid learning in practice: A lung
cancer survival decision support system in routine patient care data.
Radiotherapy & Oncology 113,1:47-53.
Lou F, Sima CS, Rusch VW, et al. (2014). Differences in patterns of recurrence in
early-stage versus locally advanced non-small cell lung cancer. Annals of
Thoracic Surgery 98,5:1755-1761.
Radiotherapy & Imaging
Backhus LM, Farjah F, Zeliadt SB, et al. (2014). Predictors of imaging surveillance
for surgically treated early-stage lung cancer. Annals of Thoracic Surgery
98,6:1944-1952.
Chan C, Lang S, Rowbottom C, et al. (2014). Intensity-modulated radiotherapy for
lung cancer: current status and future developments. Journal of Thoracic
Oncology: Official Publication of the International Association for the Study of Lung
Cancer 9,11:1598-1608.
Crabtree TD, Puri V, Chen SB, et al. (2015). Does the method of radiologic
surveillance affect survival after resection of stage I non-small cell lung cancer?.
Journal of Thoracic & Cardiovascular Surgery 149,1:45-53.e3.
Deodato F, Cilla S, Macchia G, et al. (2014). Stereotactic Radiosurgery (SRS) with
Volumetric Modulated Arc Therapy (VMAT): Interim Results of a Multi-arm Phase
I Trial (DESTROY-2). Clinical Oncology (Royal College of Radiologists) 26,12:748-756.
Jameson MG, Kumar S, Vinod SK, et al. (2014). Correlation of contouring variation
with modeled outcome for conformal non-small cell lung cancer radiotherapy.
Radiotherapy & Oncology 112,3:332-336.
Kennedy SA, Milovanovic L, Dao D, et al. (2014). Risk factors for pneumothorax
complicating radiofrequency ablation for lung malignancy: a systematic review
and meta-analysis. Journal of Vascular & Interventional Radiology 25,11:16711681.e1.
Knudtsen IS, van Elmpt W, Ollers M, et al. (2014). Impact of PET reconstruction
algorithm and threshold on dose painting of non-small cell lung cancer.
Radiotherapy & Oncology 113,2:210-214.
Lefresne S, Berthelet E, Cashman R, et al. (2015). The Vancouver rapid access
clinic for palliative lung radiation, providing more than just rapid access.
Supportive Care in Cancer 23,1:125-132.
Maguire J, Khan I, McMenemin R, et al. (2014). SOCCAR: A randomised phase II
trial comparing sequential versus concurrent chemotherapy and radical
hypofractionated radiotherapy in patients with inoperable stage III Non-Small Cell
Lung Cancer and good performance status. European journal of cancer 50,17:29392949.
Supportive Care & Symptom Management
4
Lung Cancer, January 2015
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
Badr H, Smith CB, Goldstein NE, et al. (2015). Dyadic psychosocial intervention for
advanced lung cancer patients and their family caregivers: Results of a
randomized pilot trial. Cancer 121,1:150-158.
Chambers SK, Morris BA, Clutton S, et al. (2015). Psychological wellness and
health-related stigma: a pilot study of an acceptance-focused cognitive
behavioural intervention for people with lung cancer. European Journal of Cancer
Care 24,1:60-70.
Cooley ME, Blonquist TM, Catalano PJ, et al. (2015). Feasibility of using algorithmbased clinical decision support for symptom assessment and management in
lung cancer. Journal of Pain & Symptom Management 49,1:13-26.
Dean GE, Abu Sabbah E, Yingrengreung S, et al. (2015). Sleeping with the enemy:
sleep and quality of life in patients with lung cancer. Cancer nursing 38,1:60-70.
Ironmonger L, Ohuma E, Ormiston-Smith N, et al. (2015). An evaluation of the
impact of large-scale interventions to raise public awareness of a lung cancer
symptom. British journal of cancer 112,1:207-216.
Kitazaki T, Fukuda Y, Fukahori S, et al. (2015). Usefulness of antiemetic therapy
with aprepitant, palonosetron, and dexamethasone for lung cancer patients on
cisplatin-based or carboplatin-based chemotherapy. Supportive Care in Cancer
23,1:185-190.
Rasmussen JF, Siersma V, Pedersen JH, et al. (2015). Psychosocial consequences
in the Danish randomised controlled lung cancer screening trial (DLCST). Lung
Cancer 87,1:65-72.
Surgery
Riber LP, Larsen TB and Christensen TD. (2014). Postoperative atrial fibrillation
prophylaxis after lung surgery: systematic review and meta-analysis. Annals of
Thoracic Surgery 98,6:1989-1997.
Sawabata N, Nagayasu T, Kadota Y, et al. (2015). Risk assessment of lung
resection for lung cancer according to pulmonary function: republication of
systematic review and proposals by guideline committee of the Japanese
Association for Chest Surgery 2014. General Thoracic & Cardiovascular Surgery
63,1:14-21.
Thomas PA, Berbis J, Baste JM, et al. (2015). Pneumonectomy for lung cancer:
Contemporary national early morbidity and mortality outcomes. Journal of
Thoracic & Cardiovascular Surgery 149,1:73-83.
Yamashita S, Goto T, Mori T, et al. (2014). Video-assisted thoracic surgery for lung
cancer: republication of a systematic review and a proposal by the guidelines
committee of the Japanese Association for Chest Surgery 2014. General Thoracic
& Cardiovascular Surgery 62,12:701-705.
5
Lung Cancer, January 2015
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
Please note that the journal articles you are accessing are subject to the terms and conditions
imposed by the publisher, so there will be a limit on the number of articles an individual may
download or print from a single issue of a journal. You can consult your local NHSGGC library with
any queries.
If you have any questions regarding this or any other library services please contact Library staff –
contact details are at the beginning of the bulletin.
Sources used for this bulletin: OVID databases, SIGN, NICE, Healthcare Improvement Scotland
6
Lung Cancer, January 2015
Kirsty Coltart, Subject Librarian, NHSGGC Library Network